Checkpoint Therapeutics I... (CKPT)
NASDAQ: CKPT
· Real-Time Price · USD
4.16
0.00 (0.00%)
At close: May 13, 2025, 3:34 PM
0.00% (1D)
| Bid | 4.15 |
| Market Cap | 358.66M |
| Revenue (ttm) | 41K |
| Net Income (ttm) | -56.24M |
| EPS (ttm) | -1.42 |
| PE Ratio (ttm) | -2.93 |
| Forward PE | 4.53 |
| Analyst | Hold |
| Ask | 4.16 |
| Volume | 426,663 |
| Avg. Volume (20D) | 2,664,890 |
| Open | 4.15 |
| Previous Close | 4.16 |
| Day's Range | 4.15 - 4.17 |
| 52-Week Range | 1.50 - 4.50 |
| Beta | 1.19 |
About CKPT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CKPT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CKPT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+61.13%
Checkpoint Therapeutics shares are trading higher ...
Unlock content with
Pro Subscription
10 months ago
+15.56%
Checkpoint Therapeutics shares are trading higher after the company announced it reached alignment with the FDA on its on its biologics license application resubmission strategy for cosibelimab.
2 months ago · proactiveinvestors.com
Checkpoint Therapeutics shares pop on acquisition by Sun PharmaCheckpoint Therapeutics (NASDAQ:CKPT) shares added more than 60% after it was revealed the immunology and targeted oncology firm will be acquired by Sun Pharmaceutical Industries. Under the agreement,...
